Development Level

Tdark 57 | 7,003
Tbio 6 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

osteosarcoma 15 | 7,933
interstitial cystitis 13 | 2,299
periodontitis 11 | 269
lung cancer 10 | 4,473
ulcerative colitis 10 | 2,087
Multiple myeloma 9 | 1,327
chronic lymphosyte leukemia 9 | 232
psoriasis 9 | 6,685
tuberculosis 9 | 1,563
lung adenocarcinoma 8 | 2,714
cutaneous lupus erythematosus 7 | 1,056
Amebiasis 6 | 22
non-small cell lung cancer 6 | 2,798
pancreatic cancer 6 | 2,300
Cancer 5 | 2,346
Leukemia 5 | 88
Lymphoma 5 | 57
cystic fibrosis and chronic rhinosinusitis 5 | 213
non-small cell lung carcinoma 5 | 413
primary Sjogren syndrome 5 | 788
ovarian cancer 4 | 8,491
Agammaglobulinemia, non-Bruton type 3 | 8
Chronic obstructive pulmonary disease 3 | 147
chronic rhinosinusitis 3 | 512
colon cancer 3 | 1,475
diabetes mellitus 3 | 1,663
esophageal adenocarcinoma 3 | 737
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung carcinoma 3 | 2,844
nasopharyngeal carcinoma 3 | 1,056
primary pancreatic ductal adenocarcinoma 3 | 1,271
Agammaglobulinemia 2 | 24
Allergic hypersensitivity disease 2 | 123
Breast cancer 2 | 3,098
Diffuse large B-cell lymphoma 2 | 42
Dysgammaglobulinemia 2 | 9
Lupus erythematosus 2 | 80
Macroglobulinemia 2 | 17
Myositis 2 | 24
Pick disease 2 | 1,893
X-linked agammaglobulinemia 2 | 7
cystic fibrosis 2 | 1,670
gastric cancer 2 | 436
medulloblastoma, large-cell 2 | 6,234
mucosa-associated lymphoid tissue lymphoma 2 | 480
posterior fossa group A ependymoma 2 | 1,511
subependymal giant cell astrocytoma 2 | 2,287
Acute cystitis 1 | 37
Amyloidosis 1 | 68
Arthropathy 1 | 34
Autoimmune hepatitis 1 | 13
Autoimmune thyroiditis 1 | 24
Brucellosis 1 | 24
Calcinosis 1 | 63
Candidiasis 1 | 48
Celiac disease 1 | 112
Chickenpox 1 | 6
Chlamydia 1 | 18
Cholangitis 1 | 20
Cholera 1 | 33
Diarrhea 1 | 155
Diphtheria 1 | 23
Duodenal ulcer 1 | 20
Echinococcosis 1 | 28
Gastritis 1 | 44
Gastroenteritis 1 | 46
Giardiasis 1 | 10
Glomerulonephritis 1 | 36
Goodpasture syndrome 1 | 6
Heart valve disease 1 | 24
Henoch-Schoenlein purpura 1 | 13
Hepatitis A 1 | 10
Herpes simplex 1 | 19
Herpes zoster 1 | 7
Immunoglobulin alpha deficiency 1 | 10
Leprosy 1 | 77
Measles 1 | 20
Meningoencephalitis 1 | 13
Mumps 1 | 10
Newcastle disease 1 | 13
Otitis media 1 | 32
Parotitis 1 | 6
Pelvic inflammatory disease 1 | 21
Periodontal disease 1 | 37
Pertussis 1 | 17
Pneumocystosis 1 | 18
Polyneuropathy 1 | 30
Q fever 1 | 11
Reactive arthritis 1 | 7
Respiratory Hypersensitivity 1 | 18
Rubella 1 | 14
Schistosomiasis 1 | 38
Stomatitis 1 | 19
Syphilis 1 | 18
Tetanus 1 | 66
Tonsillitis 1 | 18
Toxoplasmosis 1 | 16
Typhoid fever 1 | 22
X-linked hyper IgM syndrome 1 | 5

Tissue

Blood and immune system 50 | 17,994
Digestive Tract 50 | 18,472
Female tissues 50 | 18,646
Respiratory system 50 | 17,483
Skin and soft tissues 50 | 18,114
Liver and Pancreas 49 | 18,135
Urinary Tract 49 | 18,443
Cardiovascular System 47 | 17,957
Endocrine System 46 | 18,511
Nervous System 46 | 18,560
Male tissues 44 | 17,968

Target Family

Non-IDG 64 | 11,969
Enzyme 1 | 4,146
Kinase 1 | 634

Reactome Pathway

CD22 mediated BCR regulation 66 | 66
Signal Transduction 2,515 | 2,515
Immune System 2,183 | 2,183
Metabolism 2,131 | 2,131
Gene Expression 1,754 | 1,754
Metabolism of proteins 1,544 | 1,544
Innate Immune System 1,375 | 1,375
Signaling by GPCR 1,329 | 1,329
Developmental Biology 1,028 | 1,028
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,004 | 1,004
Adaptive Immune System 938 | 938
Disease 855 | 855
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 803 | 803
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 668 | 668
Membrane Trafficking 608 | 608
Cell Cycle 572 | 572
Neutrophil degranulation 542 | 542
Axon guidance 541 | 541
Signaling by Interleukins 500 | 500
Cell Cycle, Mitotic 470 | 470
Signalling by NGF 467 | 467
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 435 | 435
Class I MHC mediated antigen p... 430 | 430
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 423 | 423
Cellular responses to stress 415 | 415
DAP12 interactions 409 | 409
Infectious disease 391 | 391
NGF signalling via TRKA from t... 378 | 378
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 367 | 367
Diseases of signal transductio... 359 | 359
Transcriptional Regulation by ... 356 | 356
Signaling by EGFR 355 | 355
Metabolism of amino acids and ... 353 | 353
DAP12 signaling 346 | 346
Downstream signal transduction 343 | 343
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 329 | 329
Signaling by SCF-KIT 327 | 327
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 321 | 321
FCERI mediated MAPK activation 316 | 316
Signaling by Insulin receptor 312 | 312
Antigen processing: Ubiquitina... 301 | 301
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 290 | 290
Signaling by Wnt 290 | 290
IGF1R signaling cascade 289 | 289
IRS-related events triggered b... 289 | 289
Insulin receptor signalling ca... 288 | 288
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 285 | 285
MAPK family signaling cascades 283 | 283
Asparagine N-linked glycosylat... 282 | 282
Signaling by the B Cell Recept... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 277 | 277
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 268 | 268
M Phase 266 | 266
Interleukin-3, 5 and GM-CSF si... 262 | 262
RET signaling 261 | 261
Signalling to ERKs 254 | 254
Interleukin-2 signaling 253 | 253
Immunoregulatory interactions ... 252 | 252
RHO GTPase Effectors 249 | 249
VEGFR2 mediated cell prolifera... 249 | 249
Signalling to RAS 247 | 247
Interleukin receptor SHC signa... 246 | 246
G alpha (i) signalling events 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Signaling by Leptin 244 | 244
Prolonged ERK activation event... 243 | 243
MAPK1/MAPK3 signaling 242 | 242
Frs2-mediated activation 241 | 241
HIV Infection 241 | 241
ARMS-mediated activation 240 | 240
Signalling to p38 via RIT and ... 240 | 240
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 236 | 236
RAF/MAP kinase cascade 236 | 236
SHC1 events in EGFR signaling 236 | 236
SOS-mediated signalling 236 | 236
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Phospholipid metabolism 202 | 202

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ig lambda-6 chain C region IGLC6 Tdark Non-IDG -1.81183 228.7 0
Tyrosine-protein kinase Lyn LYN Tclin Kinase -2.82112 659.3 521
Immunoglobulin heavy variable 3-7 IGHV3-7 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 3-33 IGHV3-33 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 1-46 IGHV1-46 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 1-69 IGHV1-69 Tdark Non-IDG 0.00000 0
Ig lambda-7 chain C region IGLC7 Tdark Non-IDG -1.81183 228.7 0
Ig kappa chain C region IGKC Tbio Non-IDG 0.00000 0
Immunoglobulin heavy variable 4-59 IGHV4-59 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 4-39 IGHV4-39 Tdark Non-IDG 0.00000 0